Skip to main content
OpenTrials
Completed

NCT Number: NCT00308906

Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children

The purposes of this study are to identify potential gene and protein markers of aminoglycoside-induced kidney injury in infants, children and adolescents treated with aminoglycoside antibiotics.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Lousiville, Louisville, Kentucky, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(1) Hospitalized male and female newborns, infants, children and adolescents (ages birth to 18 years) with a diagnosis of suspected or proven bacterial sepsis, meningitis or other indication necessitating aminoglycoside therapy (2) hospitalized and outpatient newborns, infants, children and adolescents (ages birth to 18 years) who are not receiving aminoglycoside therapy.

Exclusion criteria

(1) Current treatment with inhaled or ophthalmic aminoglycosides (2) Prior treatment with an aminoglycoside within the last 30 days

Treatment and study plan

Aminoglycoside

Drug

Aminoglycosides will be administered and monitored as part of the routine standard of care for the subject.

Primary outcomes

  1. Indicators of renal injury

    Time frame: Pre and post treatment

Sponsors and collaborators

Lead sponsor

Virginia Commonwealth University

Other

Collaborators

  • University of Louisville

Registry information

Official study title

Assessment of Gene and Urinary Protein Expression in Aminoglycoside-treated and Untreated Infants, Children and Adolescents

Important dates

Study start
2006
Primary completion
2010
Study completion
2010
First posted
Mar 30, 2006
Registry last updated
Feb 2, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.